RB1 and ovarian serous adenocarcinoma: First, Makowski et al demonstrated significant differences in gene expression and metabolomics profiling between the ovarian tumors from the obese versus non-obese mice in a genetically engineered mouse model of serous ovarian cancer, similar to our findings in the high leptin/OB-Rb mRNA subgroup from the TCGA database.